Semaglutide has been prescribed longer and remains extremely popular due to accessibility and flexibility
Bottom line Retatrutide is still in clinical trials, with early data suggesting significant weight loss potential, while semaglutide has FDA approval with proven efficacy and safety history
The combination of all three makes Retatrutide unusually potent for fat loss, appetite control, and metabolic health
Noom Eyes GLP-1s for Longevity, Not Just Weight Loss The digital health platforms new GLP-1 Rx program pairs microdosed weight-loss drugs with biomarker testing and behavior change to target early metabolic risk For consumers intrigued by the promise of GLP-1 medications but who dont meet the BMI requirements typically tied to prescriptions, the door has largely stayed closed until now
Compounded Medication Disclosure: Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing
The starting dose costs $299 per month, identical to Willow semaglutide pricing and actually cheaper than Willow tirzepatide at $399
